O que significa “Limpar”?
O animal não carrega a mutação. Não desenvolverá a doença e não vai passar adiante.
Cachorro Polineuropatia do Malamute do Alasca (AMPN)
Alaskan Malamute Polyneuropathy (AMPN) is a genetic disorder that affects the nervous system of Alaskan Malamutes. A DNA test for AMPN can help dog owners identify whether their pets are carriers of this condition, which may lead to debilitating symptoms such as muscle weakness and impaired coordination. Early detection through DNA testing is crucial for managing the health of affected dogs, allowing for better care and informed breeding decisions. By knowing your dog's genetic status, you can take proactive steps to ensure a healthier life for your Alaskan Malamute. Don't wait—consider a DNA test today to safeguard your furry friend against AMPN. Protect your dog's well-being with this simple yet essential genetic screening.
Abreviatura: AMPN
Mutação analisada: NDRG1 c.293G>T
Herança: Autossômico Recessivo
Acrônimo
AMPN
Frequência observada
Gravidade clínica
Classificação clínica
Doenças Neurológicas
Mutação analisada
NDRG1 c.293G>T
p.(G98V)
p.(G98V)
Modo de herança
Autossômico Recessivo
Resumo do teste:
Alaskan Malamute Polyneuropathy (AMPN) is a genetic condition affecting the nervous system of Alaskan Malamutes. DNA testing for AMPN helps identify carriers and affected dogs, allowing breeders to make informed decisions to reduce the prevalence of this disorder. Symptoms may include muscle weakness and coordination issues, impacting the dog's quality of life. Early detection through genetic testing can aid in managing the condition effectively. Responsible breeding practices can help ensure healthier future generations of this beloved breed.
Disponível no pacote: Basic
Este teste de DNA está incluído a partir do nosso pacote Basic - e também faz parte dos packs Basic, Standard, Advanced, Complete.
Ver pacotes de teste de DNA →Escolha o pack que melhor se adapta à sua estratégia de criação ou saúde dos seus animais.
Understanding Alaskan Malamute Polyneuropathy (AMPN)
Alaskan Malamute Polyneuropathy (AMPN) is a hereditary neurological disorder that primarily affects Alaskan Malamutes, leading to a range of debilitating symptoms. This condition is characterized by the degeneration of peripheral nerves, which can result in significant mobility issues and impairments in the dog's overall quality of life.
Symptoms of AMPN
Dogs affected by AMPN may exhibit a variety of symptoms, which can vary in severity. Common signs include muscle weakness, difficulty in walking or running, and a noticeable decrease in coordination. As the disease progresses, affected dogs may develop tremors, a wobbly gait, and muscle atrophy. These symptoms often manifest between the ages of 6 months and 2 years, although the onset can vary.
Genetic Basis of AMPN
The condition is caused by a genetic mutation that affects the structure and function of nerve fibers. This mutation can be identified through a DNA test, which helps in diagnosing the condition before clinical signs become apparent. Understanding the genetic basis of AMPN is crucial for breeders and pet owners, as it aids in making informed decisions regarding breeding practices and the management of affected dogs.
Importância dos testes de DNA
DNA testing for AMPN plays a vital role in the early detection and management of the disease. By identifying carriers of the genetic mutation, breeders can take steps to avoid mating affected dogs, thereby reducing the incidence of the disorder in future generations. Moreover, knowing a dog’s genetic status can assist owners in making informed decisions about their pet’s care and potential lifestyle adjustments.
Managing AMPN
While there is currently no cure for AMPN, management strategies can significantly improve the quality of life for affected dogs. These may include physical therapy, pain management, and modifications to the dog's environment to accommodate mobility challenges. Regular veterinary check-ups are essential to monitor the condition and adjust treatment plans as needed.
Conclusão
Alaskan Malamute Polyneuropathy is a serious genetic condition that can severely impact the health and well-being of affected dogs. Through DNA testing, owners and breeders can take proactive steps in managing this disorder, ensuring that future generations of Alaskan Malamutes are healthier and less prone to AMPN. Understanding the implications of this condition is crucial for responsible breeding and compassionate care of affected dogs.
Raça reconhecida para o teste: Polineuropatia do Malamute do Alasca (AMPN)
- Alaskan Malamute
🧬 Interpretation of genotypes AMPN
Genótipo
Status
🟡 N/N
Não portador - sem risco
🟡 N/AMPN
Transportadora - Sem Risco
❌ AMPN/AMPN
Afetados - Em risco
FAQ: entendendo a interpretação
Um “transportador” é sério?
Não. O animal é geralmente saudável, mas pode transmitir a mutação ao seu descendência.
E se um animal for “afetado”?
Ele carrega duas cópias mutadas. Os sinais clínicos são esperados dependendo a doença. Não deveria ser criado.
Por que existem diferenças entre homem/mulher?
Algumas doenças estão ligadas ao sexo, pelo que a sua expressão varia dependendo do sexo do animal.
Prever descendência
N/N (nao-portador)
N/AMPN (Operadora)
AMPN/AMPN (Afetado)
Perguntas frequentes sobre testes de DNA
O que este teste de DNA detecta?
This DNA test detects the mutation associated with Alaskan Malamute Polyneuropathy (AMPN) in order to identify clear, carrier, or at-risk animals.
Por que testar um animal reprodutor?
Os testes de DNA ajudam os criadores a planejar acasalamentos mais seguros e a reduzir o risco de transmissão da mutação aos descendentes.
Qual é o modo de herança deste teste?
O modo de herança relatado para este teste é Autossômico Recessivo.
Qual mutação é analisada neste teste?
This test analyses the mutation NDRG1 c.293G>T.
Um animal portador é necessariamente afetado?
Não necessariamente. A interpretação depende do padrão de herança e do genótipo resultante.
Referências
Bruun Camilla S, Jäderlund Karin H, Berendt Mette, Jensen Kristine B, Spodsberg Eva H, Gredal Hanne, Shelton G Diane, Mickelson James R, Minor Katie M, Lohi Hannes, Bjerkås Inge, Stigen Oyvind, Espenes Arild, Rohdin Cecilia, Edlund Rebecca, Ohlsson Jennie, Cizinauskas Sigitas, Leifsson Páll S, Drögemüller Cord, Moe Lars, Cirera Susanna, Fredholm Merete. A Gly98Val mutation in the N-Myc downstream regulated gene 1 (NDRG1) in Alaskan Malamutes with polyneuropathy. PLoS One. 2013;8(2):e54547. doi: 10.1371/journal.pone.0054547. Epub 2013 Feb 5.